<SEC-DOCUMENT>0001628280-22-029828.txt : 20221114
<SEC-HEADER>0001628280-22-029828.hdr.sgml : 20221114
<ACCEPTANCE-DATETIME>20221114160634
ACCESSION NUMBER:		0001628280-22-029828
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		37
CONFORMED PERIOD OF REPORT:	20221114
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221114
DATE AS OF CHANGE:		20221114

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Neoleukin Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001404644
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36327
		FILM NUMBER:		221385148

	BUSINESS ADDRESS:	
		STREET 1:		SUITE 360 - 1616 EASTLAKE AVE EAST
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98102
		BUSINESS PHONE:		206-732-2133

	MAIL ADDRESS:	
		STREET 1:		SUITE 360 - 1616 EASTLAKE AVE EAST
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98102

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AQUINOX PHARMACEUTICALS, INC
		DATE OF NAME CHANGE:	20140128

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AQUINOX PHARMACEUTICALS (USA) INC
		DATE OF NAME CHANGE:	20070626
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>nltx-20221114.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:a4de0f8f-9b24-4c62-a03f-00cc0314cc07,g:568ab273-9e49-4658-875b-871c7587e91a,d:ab108baa2e7743e39cd7bca23aedae72--><html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>nltx-20221114</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i1f217638e60542bc9f1653bb43bd5038_D20221114-20221114" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmFiMTA4YmFhMmU3NzQzZTM5Y2Q3YmNhMjNhZWRhZTcyL3NlYzphYjEwOGJhYTJlNzc0M2UzOWNkN2JjYTIzYWVkYWU3Ml80L2ZyYWc6OTc5NTk1NTQyNGY4NGEwY2EyMjg0MTU3ZGNiNjU4NDQvdGFibGU6MjNmODE2YzE1N2JiNGY3YWI1YzNkZWQ2YmQ2ZGQ1ZGIvdGFibGVyYW5nZToyM2Y4MTZjMTU3YmI0ZjdhYjVjM2RlZDZiZDZkZDVkYl8yLTEtMS0xLTUyMzEz_d7d17907-e95a-4fd6-9c87-ef17f65846b7">0001404644</ix:nonNumeric><ix:nonNumeric contextRef="i1f217638e60542bc9f1653bb43bd5038_D20221114-20221114" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmFiMTA4YmFhMmU3NzQzZTM5Y2Q3YmNhMjNhZWRhZTcy